Intracellular and extracellular expression of Bacillus thuringiensis crystal protein Cry5B in Lactococcus lactis for use as an anthelminthic

Applied and Environmental Microbiology

Volumn 82, Issue 4, 2016, Pages 1286-1294

  Durmaz, Evelyn ^a   Hu, Yan ^b   Aroian, Raffi V ^b   Klaenhammer, Todd R ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; BACTERIAL PROTEIN; ENDOTOXIN; HEMOLYSIN; INSECTICIDAL CRYSTAL PROTEIN, BACILLUS THURINGIENSIS; NISIN; RECOMBINANT PROTEIN;

ANIMAL; BIOSYNTHESIS; CAENORHABDITIS ELEGANS; DRUG EFFECTS; GENE DOSAGE; GENE EXPRESSION; GENE VECTOR; GENETICS; LACTOCOCCUS LACTIS; METABOLISM; MICROBIAL VIABILITY; MOLECULAR CLONING; PLASMID; PROMOTER REGION; PROTEIN TRANSPORT; SURVIVAL ANALYSIS; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; ANTHELMINTICS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CAENORHABDITIS ELEGANS; CLONING, MOLECULAR; ENDOTOXINS; GENE DOSAGE; GENE EXPRESSION; GENETIC VECTORS; HEMOLYSIN PROTEINS; LACTOCOCCUS LACTIS; MICROBIAL VIABILITY; NISIN; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; TRANSCRIPTIONAL ACTIVATION;

EID: 84957922300     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02365-15     Document Type: Article

References (46)

1. Blair P, Diemert D. 2015. Update on prevention and treatment of intestinal helminth infections. Curr Infect Dis Rep 17:465. http://dx.doi.org/10.1007/s11908-015-0465-x.
2. Somvanshi VS, Ellis BL, Hu Y, Aroian RV. 2014. Nitazoxanide: nematicidal mode of action and drug combination studies. Mol Biochem Parasitol 193:1-8. http://dx.doi.org/10.1016/j.molbiopara.2013.12.002.
3. Hu Y, Aroian RV. 2012. Promise of Bacillus thuringiensis crystal proteins as anthelmintics, p 267-281. In Caffrey CR (ed), Parasitic helminths: targets, screens, drugs and vaccines, 1st ed. Wiley-Blackwell, Hoboken, NJ.
4. Hu Y, Miller MM, Derman AI, Ellis BL, Monnerat RG, Pogliano J, Aroian RV. 2013. A Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases. Appl Environ Microbiol 79:5527-5532. http://dx.doi.org/10.1128/AEM.01854-13.
5. Urban JF, Jr, Hu Y, Miller MM, Scheib U, Yiu YY, Aroian RV. 2013. Bacillus thuringiensis-derived Cry5B has potent anthelmintic activity against Ascaris suum. PLoS Negl Trop Dis 7:e2263. http://dx.doi.org/10.1371/journal.pntd.0002263.
6. Hu Y, Georghiou SB, Kelleher AJ, Aroian RV. 2010. Bacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in mice. PLoS Neglect Trop Dis 4:e614. http://dx.doi.org/10.1371/journal.pntd.0000614.
7. Cappello M, Bungiro RD, Harrison LM, Bischof LJ, Griffitts JS, Barrows BD, Aroian RV. 2006. A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum. Proc Natl Acad Sci U S A 103:15154-15159. http://dx.doi.org/10.1073/pnas.0607002103.
8. Hu Y, Aroian RV. 2012. Bacterial pore-forming proteins as anthelmintics. Invertebr Neurosci 12:37-41. http://dx.doi.org/10.1007/s10158-012-0135-8.
9. Li XQ, Tan A, Voegtline M, Bekele S, Chen CS, Aroian RV. 2008. Expression of Cry5B protein from Bacillus thuringiensis in plant roots confers resistance to root-knot nematode. Biol Control 47:97-102. http://dx.doi.org/10.1016/j.biocontrol.2008.06.007.
10. Schnepf E, Crickmore N, Van Rie J, Lereclus D, Baum J, Feitelson J, Zeigler DR, Dean DH. 1998. Bacillus thuringiensis and its pesticidal crystal proteins. Microbiol Mol Biol Rev 62:775-806.
11. Pontes DS, de Azeyedo MSP, Chatel JM, Langella P, Azeyedo V, Miyoshi A. 2011. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif 79:165-175. http://dx.doi.org/10.1016/j.pep.2011.06.005.
12. Wyszynska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK. 2015. Lactic acid bacteria-20 years exploring their potential as live vectors for mucosal vaccination. Appl Microbiol Biotechnol 99:2967-2977. http://dx.doi.org/10.1007/s00253-015-6498-0.
13. LeBlanc JG, Aubry C, Cortes-Perez NG, de LeBlanc AD, Vergnolle N, Langella P, Azevedo V, Chatel JM, Miyoshi A, Bermudez-Humaran LG. 2013. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol Lett 344:1-9. http://dx.doi.org/10.1111/1574-6968.12159.
14. Daniel C, Poiret S, Dennin V, Boutillier D, Pot B. 2013. Bioluminescence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice. Appl Environ Microbiol 79:1086-1094. http://dx.doi.org/10.1128/AEM.03221-12.
15. Faye T, Tamburello A, Vegarud GE, Skeie S. 2012. Survival of lactic acid bacteria from fermented milks in an in vitro digestion model exploiting sequential incubation in human gastric and duodenum juice. J Dairy Sci 95:558-566. http://dx.doi.org/10.3168/jds.2011-4705.
16. Drouault S, Corthier G, Ehrlich SD, Renault P. 1999. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 65:4881-4886.
17. Klijn N, Weerkamp AH, de Vos WM. 1995. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol 61:2771-2774.
18. Dianawati D, Mishra V, Shah NP. 2013. Stability of microencapsulated Lactobacillus acidophilus and Lactococcus lactis ssp cremoris during storage at room temperature at low a(w). Food Res Int 50:259-265. http://dx.doi.org/10.1016/j.foodres.2012.10.023.
19. Soccol CR, Vandenberghe LPD, Spier MR, Medeiros ABP, Yamaguishi CT, Lindner JD, Pandey A, Thomaz-Soccol V. 2010. The potential of probiotics: a review. Food Technol Biotechnol 48:413-434.
20. Adams CA. 2010. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23:37-46. http://dx.doi.org/10.1017/S0954422410000090.
21. Taverniti V, Guglielmetti S. 2011. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 6:261-274. http://dx.doi.org/10.1007/s12263-011-0218-x.
22. Durmaz E, Klaenhammer TR. 1995. A starter culture rotation strategy incorporating paired restriction/modification and abortive infection bacteriophage defenses in a single Lactococcus lactis strain. Appl Environ Microbiol 61:1266-1273.
23. Walker SA, Klaenhammer TR. 2000. An explosive antisense RNA strategy for inhibition of a lactococcal bacteriophage. Appl Environ Microbiol 66:310-319. http://dx.doi.org/10.1128/AEM.66.1.310-319.2000.
24. Walker SA, Klaenhammer TR. 2001. Leaky Lactococcus cultures that externalize enzymes and antigens independently of culture lysis and secretion and export pathways. Appl Environ Microbiol 67:251-259. http://dx.doi.org/10.1128/AEM.67.1.251-259.2001.
25. Hillier AJ, Jago GR. 1982. L-Lactate dehydrogenase, Fdp-activated, from Streptococcus cremoris. Methods Enzymol 89:362-367. http://dx.doi.org/10.1016/S0076-6879(82)89065-4.
26. Goh YJ, Lee JH, Hutkins RW. 2007. Functional analysis of the fructooligosaccharide utilization operon in Lactobacillus paracasei 1195. Appl Environ Microbiol 73:5716-5724. http://dx.doi.org/10.1128/AEM.00805-07.
27. Huffman DL, Abrami L, Sasik R, Corbeil J, van der Goot FG, Aroian RV. 2004. Mitogen-activated protein kinase pathways defends against bacterial pore-forming toxins. Proc Natl Acad SciUSA101:10995-11000. http://dx.doi.org/10.1073/pnas.0404073101.
28. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, Tanaka-Hino M, Hisamoto N, Matsumoto K, Tan MW, Ausubel FM. 2002. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297:623-626. http://dx.doi.org/10.1126/science .1073759.
29. Tanaka-Hino M, Sagasti A, Hisamoto N, Kawasaki M, Nakano S, Ninomiya-Tsuji J, Bargmann CI, Matsumoto K. 2002. SEK-1 MAPKK mediates Ca2_signaling to determine neuronal asymmetric development in Caenorhabditis elegans. EMBO Rep 3:56-62. http://dx.doi.org/10.1093/embo-reports/kvf001.
30. Brenner S. 1974. Genetics of Caenorhabditis elegans. Genetics 77:71-94.
31. Hu Y, Platzer EG, Bellier A, Aroian RV. 2010. Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. Proc Natl Acad Sci U S A 107:5955-5960. http://dx.doi.org/10.1073/pnas.0912327107.
32. O'Sullivan DJ, Klaenhammer TR. 1993. High-copy-number and low-copynumber Lactococcus shuttle cloning vectors with features for clone screening. Gene 137:227-231. http://dx.doi.org/10.1016/0378-1119(93)90011-Q.
33. Le Loir Y, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermudez-Humaran LG, Nouaille S, Ribeiro LA, Leclercq S, Gabriel JE, Guimaraes VD, Oliveira MN, Charlier C, Gautier M, Langella P. 2005. Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 4:2. http://dx.doi.org/10.1186/1475-2859-4-2.
34. Oddone GM, Mills DA, Block DE. 2009. Incorporation of nisI-mediated nisin immunity improves vector-based nisin-controlled gene expression in lactic acid bacteria. Plasmid 61:151-158. http://dx.doi.org/10.1016/j.plasmid.2008.12.001.
35. Kim JH, Mills DA. 2007. Improvement of a nisin-inducible expression vector for use in lactic acid bacteria. Plasmid 58:275-283. http://dx.doi.org/10.1016/j.plasmid.2007.05.004.
36. van de Guchte M, Kodde J, van der Vossen JM, Kok J, Venema G. 1990. Heterologous gene expression in Lactococcus lactis subsp. lactis: synthesis, secretion, and processing of the Bacillus subtilis neutral protease. Appl Environ Microbiol 56:2606-2611.
37. Alkhatib Z, Abts A, Mavaro A, Schmitt L, Smits SHJ. 2012. Lantibiotics:how do producers become self-protected? J Biotechnol 159:145-154. http://dx.doi.org/10.1016/j.jbiotec.2012.01.032.
38. Pasztor L, Ziebandt AK, Nega M, Schlag M, Haase S, Franz-Wachtel M, Madlung J, Nordheim A, Heinrichs DE, Gotz F. 2010. Staphylococcal major autolysin (Atl) is involved in excretion of cytoplasmic proteins. J Biol Chem 285:36794-36803. http://dx.doi.org/10.1074/jbc .M110.167312.
39. Visweswaran GRR, Steen A, Leenhouts K, Szeliga M, Ruban B, Hesseling-Meinders A, Dijkstra BW, Kuipers OP, Kok J, Buist G. 2013. AcmD, a homolog of the major autolysin AcmA of Lactococcus lactis, binds to the cell wall and contributes to cell separation and autolysis. PLoS One 8:e72167. http://dx.doi.org/10.1371/journal.pone.0072167.
40. Tuler TR, Callanan MJ, Klaenhammer TR. 2002. Overexpression of peptidases in Lactococcus and evaluation of their release from leaky cells. J Dairy Sci 85:2438-2450. http://dx.doi.org/10.3168/jds.S0022-0302(02)74326-9.
41. Ventura M, Zomer A, Canchaya C, O'Connell-Motherway M, Kuipers O, Turroni F, Ribbera A, Foroni E, Buist G, Wegmann U, Shearman C, Gasson MJ, Fitzgerald GF, Kok J, van Sinderen D. 2007. Comparative analyses of prophage-like elements present in two Lactococcus lactis strains. Appl Environ Microbiol 73:7771-7780. http://dx.doi.org/10.1128/AEM .01273-07.
42. Durmaz E, Klaenhammer TR. 2000. Genetic analysis of chromosomal regions of Lactococcus lactis acquired by recombinant lytic phages. Appl Environ Microbiol 66:895-903. http://dx.doi.org/10.1128/AEM.66.3.895-903.2000.
43. +31 and its use in the development of expression systems for Lactococcus lactis. Ph.D. thesis. North Carolina State University, Raleigh, NC.
44. Wegmann U, O'Connell-Motherwy M, Zomer A, Buist G, Shearman C, Canchaya C, Ventura M, Goesmann A, Gasson MJ, Kuipers OP, van Sinderen D, Kok J. 2007. Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp. cremoris MG1363. J Bacteriol 189:3256-3270. http://dx.doi.org/10.1128/JB.01768-06.
45. +). Appl Environ Microbiol 55:2416-2419.
46. Wei JZ, Hale K, Carta L, Platzer E, Wong C, Fang SC, Aroian RV. 2003. Bacillus thuringiensis crystal proteins that target nematodes. Proc Natl Acad Sci U S A 100:2760-2765. http://dx.doi.org/10.1073/pnas .0538072100.